Form 4: Maravai LifeSciences CFO Kevin Herde Acquires Shares Through Employee Stock Purchase Plan

Kevin Herde, CFO of Maravai LifeSciences Holdings, Inc., reports the acquisition of 1,780 shares of Class A Common Stock through the company's Employee Stock Purchase Plan.

Summary

• On April 30, 2024, Kevin Herde, the Chief Financial Officer of Maravai LifeSciences Holdings, Inc., acquired 1,780 shares of Class A Common Stock.
• The shares were purchased at a price of $5.70 each.
• This transaction was conducted through the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan.
• Following the transaction, Herde directly owns 334,694 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The CFO's participation in the Employee Stock Purchase Plan could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares acquired through an existing employee program.

Key Dates